I - TRANSLATIONAL SCIENCE
1. Molecular pathways and targets in B cell progenitor acute lymphoblastic leukemia
2. Genetic Mechanisms in T-Cell Acute Lymphoblastic Leukemia
3. Minimal Residual Disease in Acute Lymphoblastic Leukemia - Techniques and Application
II - THERAPEUTICS
4. Treatment of Pediatric B and T cell ALL 5. Treatment of Adult B and T cell Acute Lymphoblastic Leukemia: An Overview of Current Treatments and Novel Advances
6. Acute Lymphoblastic Leukemia in Infants: A distinctive, high risk subtype of childhood ALL
7. Treatment of Elderly Patients with Acute Lymphoblastic Leukemia
8. Treatment of Childhood Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia
9. Treatment of adult Philadelphia chromosome positive ALL
10. Treatment of Ph-like ALL
11. Prophylaxis and treatment of central nervous system (CNS) ALL
12. Late effects of therapy of acute lymphoblastic leukemia
III - NEW AND EXISTING MODALITIES OF THERAPY
13. Monoclonal Antibody Based Treatment and Other New Agents for B-Lineage ALL
14. New Agents for the Treatment of T-Cell ALL
15. The development and management of treatment with chimeric-antigen receptor T cell (CAR-T)
16. Hematopoietic Stem Cell Transplantation in Adults with Acute Lymphoblastic Leukemia (ALL)
17. Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia
